SOROS FUND MANAGEMENT LLC 13D/13G Filings for Acorda Therapeutics, Inc. (ACOR)

SOROS FUND MANAGEMENT LLC 13D and 13G filings for Acorda Therapeutics, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2022-06-10
4:24 pm
Unchanged
2022-06-02 13G Acorda Therapeutics, Inc.
ACOR
SOROS FUND MANAGEMENT LLC 0
0.000%
0
(Unchanged)
Filing